187 related articles for article (PubMed ID: 32711551)
1. Accuracy of time to treatment estimates in the CRASH-3 clinical trial: impact on the trial results.
Mansukhani R; Frimley L; Shakur-Still H; Sharples L; Roberts I
Trials; 2020 Jul; 21(1):681. PubMed ID: 32711551
[TBL] [Abstract][Full Text] [Related]
2. Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT.
Roberts I; Shakur-Still H; Aeron-Thomas A; Beaumont D; Belli A; Brenner A; Cargill M; Chaudhri R; Douglas N; Frimley L; Gilliam C; Geer A; Jamal Z; Jooma R; Mansukhani R; Miners A; Pott J; Prowse D; Shokunbi T; Williams J
Health Technol Assess; 2021 Apr; 25(26):1-76. PubMed ID: 33928903
[TBL] [Abstract][Full Text] [Related]
3. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.
CRASH-3 trial collaborators
Lancet; 2019 Nov; 394(10210):1713-1723. PubMed ID: 31623894
[TBL] [Abstract][Full Text] [Related]
4. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
Roberts I; Shakur H; Coats T; Hunt B; Balogun E; Barnetson L; Cook L; Kawahara T; Perel P; Prieto-Merino D; Ramos M; Cairns J; Guerriero C
Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634
[TBL] [Abstract][Full Text] [Related]
5. A nested mechanistic sub-study into the effect of tranexamic acid versus placebo on intracranial haemorrhage and cerebral ischaemia in isolated traumatic brain injury: study protocol for a randomised controlled trial (CRASH-3 Trial Intracranial Bleeding Mechanistic Sub-Study [CRASH-3 IBMS]).
Mahmood A; Roberts I; Shakur H
Trials; 2017 Jul; 18(1):330. PubMed ID: 28716153
[TBL] [Abstract][Full Text] [Related]
6. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury--a nested randomised, placebo-controlled trial.
Perel P; Al-Shahi Salman R; Kawahara T; Morris Z; Prieto-Merino D; Roberts I; Sandercock P; Shakur H; Wardlaw J
Health Technol Assess; 2012; 16(13):iii-xii, 1-54. PubMed ID: 22417901
[TBL] [Abstract][Full Text] [Related]
7. Effect of tranexamic acid on intracranial haemorrhage and infarction in patients with traumatic brain injury: a pre-planned substudy in a sample of CRASH-3 trial patients.
Mahmood A; Needham K; Shakur-Still H; Harris T; Jamaluddin SF; Davies D; Belli A; Mohamed FL; Leech C; Lotfi HM; Moss P; Lecky F; Hopkins P; Wong D; Boyle A; Wilson M; Darwent M; Roberts I
Emerg Med J; 2021 Apr; 38(4):270-278. PubMed ID: 33262252
[TBL] [Abstract][Full Text] [Related]
8. Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial.
Brenner A; Belli A; Chaudhri R; Coats T; Frimley L; Jamaluddin SF; Jooma R; Mansukhani R; Sandercock P; Shakur-Still H; Shokunbi T; Roberts I;
Crit Care; 2020 Nov; 24(1):560. PubMed ID: 33172504
[TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid in traumatic brain injury: an explanatory study nested within the CRASH-3 trial.
CRASH-3 Intracranial Bleeding Mechanistic Study Collaborators
Eur J Trauma Emerg Surg; 2021 Feb; 47(1):261-268. PubMed ID: 32076783
[TBL] [Abstract][Full Text] [Related]
10. Effect of Out-of-Hospital Tranexamic Acid vs Placebo on 6-Month Functional Neurologic Outcomes in Patients With Moderate or Severe Traumatic Brain Injury.
Rowell SE; Meier EN; McKnight B; Kannas D; May S; Sheehan K; Bulger EM; Idris AH; Christenson J; Morrison LJ; Frascone RJ; Bosarge PL; Colella MR; Johannigman J; Cotton BA; Callum J; McMullan J; Dries DJ; Tibbs B; Richmond NJ; Weisfeldt ML; Tallon JM; Garrett JS; Zielinski MD; Aufderheide TP; Gandhi RR; Schlamp R; Robinson BRH; Jui J; Klein L; Rizoli S; Gamber M; Fleming M; Hwang J; Vincent LE; Williams C; Hendrickson A; Simonson R; Klotz P; Sopko G; Witham W; Ferrara M; Schreiber MA
JAMA; 2020 Sep; 324(10):961-974. PubMed ID: 32897344
[TBL] [Abstract][Full Text] [Related]
11. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.
; Roberts I; Shakur H; Afolabi A; Brohi K; Coats T; Dewan Y; Gando S; Guyatt G; Hunt BJ; Morales C; Perel P; Prieto-Merino D; Woolley T
Lancet; 2011 Mar; 377(9771):1096-101, 1101.e1-2. PubMed ID: 21439633
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a prognostic model to predict death in patients with traumatic bleeding, and evaluation of the effect of tranexamic acid on mortality according to baseline risk: a secondary analysis of a randomised controlled trial.
Perel P; Prieto-Merino D; Shakur H; Roberts I
Health Technol Assess; 2013 Jun; 17(24):1-45, v-vi. PubMed ID: 23782457
[TBL] [Abstract][Full Text] [Related]
13. CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial.
Dewan Y; Komolafe EO; Mejía-Mantilla JH; Perel P; Roberts I; Shakur H;
Trials; 2012 Jun; 13():87. PubMed ID: 22721545
[TBL] [Abstract][Full Text] [Related]
14. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
[TBL] [Abstract][Full Text] [Related]
15. Traumatic injury clinical trial evaluating tranexamic acid in children (TIC-TOC): study protocol for a pilot randomized controlled trial.
Nishijima DK; VanBuren J; Hewes HA; Myers SR; Stanley RM; Adelson PD; Barnhard SE; Bobinski M; Ghetti S; Holmes JF; Roberts I; Schalick WO; Tran NK; Tzimenatos LS; Michael Dean J; Kuppermann N;
Trials; 2018 Oct; 19(1):593. PubMed ID: 30376893
[TBL] [Abstract][Full Text] [Related]
16. Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study).
CRASH-2 Collaborators, Intracranial Bleeding Study
BMJ; 2011 Jul; 343():d3795. PubMed ID: 21724564
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of tranexamic acid for the treatment of traumatic brain injury, based on the results of the CRASH-3 randomised trial: a decision modelling approach.
Williams J; Roberts I; Shakur-Still H; Lecky FE; Chaudhri R; Miners A
BMJ Glob Health; 2020 Sep; 5(9):. PubMed ID: 32878899
[TBL] [Abstract][Full Text] [Related]
18. Antifibrinolytic drugs for acute traumatic injury.
Ker K; Roberts I; Shakur H; Coats TJ
Cochrane Database Syst Rev; 2015 May; 2015(5):CD004896. PubMed ID: 25956410
[TBL] [Abstract][Full Text] [Related]
19. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2) A randomised, placebo-controlled trial.
Williams-Johnson JA; McDonald AH; Strachan GG; Williams EW
West Indian Med J; 2010 Dec; 59(6):612-24. PubMed ID: 21702233
[TBL] [Abstract][Full Text] [Related]
20. Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial.
Roberts I; Perel P; Prieto-Merino D; Shakur H; Coats T; Hunt BJ; Lecky F; Brohi K; Willett K;
BMJ; 2012 Sep; 345():e5839. PubMed ID: 22968527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
